Denali Therapeutics Inc. (DNLI) Corporate Subsidiaries
Denali Therapeutics Inc. (DNLI) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: DNLI
CIK: 1714899
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerJoseph Muscat
Audit LocationSan Mateo, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-09 | 2026-09-04 | FORM 4 | 0002124755-26-000007 | View SEC Doc Filr Page |
| 144 | 2026-09-04 | — | 144 Filing | 0002124755-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-02 | FORM 4 | 0001797826-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | FORM 4 | 0001724311-26-000014 | View SEC Doc Filr Page |
| 144 | 2026-09-02 | — | 144 Filing | 0001950047-26-009017 | View SEC Doc Filr Page |
| 144 | 2026-09-01 | — | 144 Filing | 0001950047-26-008944 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-12 | FORM 4 | 0001724310-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-11 | FORM 4 | 0001724311-26-000013 | View SEC Doc Filr Page |
| 144 | 2026-08-11 | — | 144 Filing | 0001724311-26-000012 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001714899-26-000097 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001714899-26-000096 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-04 | — | SCHEDULE 13G/A Filing | 0001088875-26-000056 | View SEC Doc Filr Page |
| 8-K | 2026-07-28 | 2026-07-27 | 8-K | 0001714899-26-000086 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-08 | — | SCHEDULE 13G/A Filing | 0001897612-26-000525 | View SEC Doc Filr Page |
| 8-K | 2026-06-18 | 2026-06-12 | 8-K | 0001714899-26-000081 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | FORM 4 | 0001189130-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | FORM 4 | 0001478007-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | FORM 4 | 0001666236-26-000015 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | FORM 4 | 0001578200-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | FORM 4 | 0001797826-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | FORM 4 | 0001816206-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | FORM 4 | 0001754371-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | 4 | 0001193125-26-259680 | View SEC Doc Filr Page |
| 8-K | 2026-06-04 | 2026-06-03 | 8-K | 0001714899-26-000074 | View SEC Doc Filr Page |
| 8-K | 2026-05-22 | 2026-05-21 | 8-K | 0001714899-26-000070 | View SEC Doc Filr Page |